Glaucoma Webinar Still Available!

July 27, 2017

CE imageDon’t miss an opportunity to earn 2 hours of Category 1 CE credit toward your MOC! Diplomates and active candidates who were unable to attend the July 19th webinar “Advances in Diagnosis and Treatment of Glaucoma,” have a second chance to benefit from this excellent presentation by Dr. Mitchell Dul. The video recording is available through GoToWebinar until August 10th. Register and view the recording before then and receive full credit toward your MOC.

Over 150 optometrists attended the live webinar and the feedback was overwhelmingly positive.

“It exceeded my expectations!  Wonderfully up to date, informative, practical.”

“Great speaker! New, valuable info given (even for an OD practicing in MA where we cannot treat glaucoma).”

“It was a great lecture, and very easy to follow. Great glaucoma review.”

To access the video, click here, and log into GoToWebinar.

I'M A DIPLOMATE/CANDIDATE

LEARNING BUILDER ACCOUNT ACCESS

Check Board Certification Status

By going through the voluntary process of becoming board certified, our Diplomates demonstrate competence beyond entry level.

Upcoming Events

Stay in the know about exams, training, and more by visiting our events page.

Webinar: Clinical Quandaries

May 8, 2025 @ 7:00 pm - 9:00 pm CDT
Save the date for Thursday May 8, 2025 to attend Clinical Quandaries, presented by Dr. Paul Ajamian. This course will...
More About Event > about Webinar: Clinical Quandaries

ABO Annual Meeting

Jun 24, 2025 @ 9:00 am - 4:30 pm CDT
The American Board of Optometry annual Board of Directors meeting will take place in Minneapolis, MN in conjunction with Optometry's...
More About Event > about ABO Annual Meeting

Optometry’s Meeting

Jun 25, 2025 @ 6:00 pm - Jun 27, 2025 @ 4:30 pm CDT
Attending Optometry's Meeting in Minneapolis? Visit the American Board of Optometry at booth 630 in the exhibit hall on Wednesday,...
More About Event > about Optometry’s Meeting

SUBSCRIBE TO OUR NEWSLETTER

  • This field is for validation purposes and should be left unchanged.